Loading…

Nippon Soda announced a 10 billion yen investment to increase production capacity of pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose) at its Nihongi plant in Joetsu, Niigata. Capacity will be increased 1.5 times, with commercial operation expected in the first half of fiscal 2026.
“当社は、医薬品添加剤「NISSO HPC」(ヒドロキシプロピルセルロース)の世界的な需要拡大に対応するため、生産能力の増強を決定いたしましたので、お知らせいたします。”nikkei.com
Summarized from public sources; check the original articles before acting on it.